Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Brophy

Showing results (101-110 of 245) with videos related to

Pageof 25
Sort By:
Pharmacoepidemiology and Drug Safety|November 24, 2011
Dopamine agonist use and the risk of heart failureChristel Renoux, Sophie Dell'Aniello, James M Brophy, et al.
Pharmacotherapy|March 24, 2006
Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control studyMahyar Etminan, Bin Zhang, Mark Fitzgerald, et al.
Journal of Insurance Medicine (New York, N.Y.)|February 3, 2005
Geographical variations in post myocardial infarction mortality and their impact on risk selectionAbdelouahed Naslafkih, Nandini Dendukuri, James M Brophy, et al.
Archives of Internal Medicine|August 11, 2010
Gout, allopurinol use, and heart failure outcomesGeorge Thanassoulis, James M Brophy, Hugues Richard, et al.
Journal of Clinical Psychopharmacology|July 10, 2014
Risperidone use and risk for gynecomastia in menMahyar Etminan, Benji Heran, Bruce Carleton, et al.
CNS Drugs|November 21, 2015
Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational StudiesTanja Tran, James M Brophy, Samy Suissa, et al.
Journal of the American Heart Association|October 11, 2019
Mortality Benefit of Alirocumab: A Bayesian PerspectiveChristopher Labos, James M Brophy, Allan Sniderman, et al.
JAMA|July 2, 2009
Adverse outcomes associated with use of proton pump inhibitors and clopidogrelVerena Schneider-Lindner, Kristian B Filion, James M Brophy
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 2005
Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic reviewNandini Dendukuri, Vania Costa, Maurice McGregor, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 19, 2007
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleedingJoseph A Delaney, Lucie Opatrny, James M Brophy, et al.
Pageof 25

Showing results (101-110 of 245) with videos related to

Sort By:
Pageof 25
Pharmacoepidemiology and Drug Safety|November 24, 2011
Dopamine agonist use and the risk of heart failureChristel Renoux, Sophie Dell'Aniello, James M Brophy, et al.
Pharmacotherapy|March 24, 2006
Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control studyMahyar Etminan, Bin Zhang, Mark Fitzgerald, et al.
Journal of Insurance Medicine (New York, N.Y.)|February 3, 2005
Geographical variations in post myocardial infarction mortality and their impact on risk selectionAbdelouahed Naslafkih, Nandini Dendukuri, James M Brophy, et al.
Archives of Internal Medicine|August 11, 2010
Gout, allopurinol use, and heart failure outcomesGeorge Thanassoulis, James M Brophy, Hugues Richard, et al.
Journal of Clinical Psychopharmacology|July 10, 2014
Risperidone use and risk for gynecomastia in menMahyar Etminan, Benji Heran, Bruce Carleton, et al.
CNS Drugs|November 21, 2015
Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational StudiesTanja Tran, James M Brophy, Samy Suissa, et al.
Journal of the American Heart Association|October 11, 2019
Mortality Benefit of Alirocumab: A Bayesian PerspectiveChristopher Labos, James M Brophy, Allan Sniderman, et al.
JAMA|July 2, 2009
Adverse outcomes associated with use of proton pump inhibitors and clopidogrelVerena Schneider-Lindner, Kristian B Filion, James M Brophy
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 20, 2005
Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic reviewNandini Dendukuri, Vania Costa, Maurice McGregor, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 19, 2007
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleedingJoseph A Delaney, Lucie Opatrny, James M Brophy, et al.
Pageof 25